Anti-Human CXCL10/IP-10 Rabbit Recombinant Antibody, PBS Only
CXCL10/IP-10 Uni-rAbTM Recombinant Antibody for FC (Intra)
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
FC (Intra)
Conjugate
Unconjugated
CloneNo.
242013E12
验证数据展示
Planning an IHC experiment? We recommend our IHCeasy CXCL10/IP10 Ready-To-Use IHC Kit. CXCL10/IP10 primary antibody included.
产品信息
98265-1-PBS targets CXCL10/IP-10 in FC (Intra) applications and shows reactivity with human samples.
Tested Applications | FC (Intra) Application Description |
Tested Reactivity | human |
Immunogen | Recombinant protein 种属同源性预测 |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Full Name | chemokine (C-X-C motif) ligand 10 |
Synonyms | CXCL10, CXCL10/IP10, IP10, CXCL 10, C-X-C motif chemokine 10 |
Calculated Molecular Weight | 11 kDa |
GenBank Accession Number | BC010954 |
Gene Symbol | CXCL10 |
Gene ID (NCBI) | 3627 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purfication |
UNIPROT ID | P02778 |
Storage Buffer | PBS Only |
Storage Conditions | Store at -80°C. The product is shipped with ice packs. Upon receipt, store it immediately at -80°C |
背景介绍
CXCL10 (also known as IP-10) is a member of the CXC chemokine family which binds to the CXCR3 receptor to exert its biological effects. CXCL10 is a 12-kDa protein and constitutes two internal disulfide cross bridges. The predicted signal peptidase cleavage generates a 10-kDa secreted polypeptide with four conserved cysteine residues in the N-terminal. The CXCL10 gene localizes on chromosome 4 at band q21, a locus associated with an acute monocytic/B-lymphocyte lineage leukemia exhibiting translocation of t (4; 11) (q21; q23). CXCL10 mediates leukocyte trafficking, adaptive immunity, inflammation, haematopoiesis and angiogenesis. Under proinflammatory conditions CXCL10 is secreted from a variety of cells, such as leukocytes, activated neutrophils, eosinophils, monocytes, epithelial cells, endothelial cells, stromal cells (fibroblasts) and keratinocytes in response to IFN-γ.